Ritalin (methylphenidate hydrochloride)

Ritalin is one of the most well-known brand names for methylphenidate, a stimulant medication primarily used to treat Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy. The brand's history is deeply rooted in Swiss pharmaceutical innovation, having been synthesized in 1944 by chemist Leandro Panizzon at the Swiss company Ciba. It was famously named after his wife, Marguerite (nicknamed Rita), who used the substance to improve her tennis game.

Today, the brand belongs to Novartis, which was formed in 1996 through the merger of Ciba-Geigy and Sandoz. As a global pharmaceutical giant, Novartis manages the production and distribution of Ritalin across various international markets. While the historical heart of the brand is Basel, Switzerland, manufacturing takes place in multiple specialized pharmaceutical facilities across Europe and North America to meet global demand.